Health Canada Ponders UK Model On Easing Biosimilar Study Requirements

US FDA Stand Unchanged For Now

 
• By Vibha Ravi
  
Panelists at AAM's Gx+Biosims Conference 2021
Panelists At AAM (From Left To Right) - Aaron Josephson, Teva Pharma; Hillel Cohen, Sandoz; Celia Lourenco, Health Canada; Stacey Ricci, FDA; Cory Wohlbach, Teva Pharma • Source: Association For Accessible Medicines
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation